Bionano Genomics earnings were -$83.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BNGO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.1M, down 84.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BNGO reported annual earnings of -$112.0M, with -51.8% growth. The next BNGO earnings date is Jun 18, 2025.
What were Bionano Genomics's earnings last quarter?
On BNGO's earnings call on Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q1 2025 earnings per share (EPS) of -$1.15, up 96.78% year over year. Total BNGO earnings for the quarter were -$3.10 million. In the same quarter last year, Bionano Genomics's earnings per share (EPS) was -$35.75.
The next BNGO earnings call is Invalid Date. Add BNGO to your watchlist to be reminded of Bionano Genomics's next earnings date.
Is Bionano Genomics profitable or losing money?
As of the last Bionano Genomics earnings report, Bionano Genomics is currently losing money. Bionano Genomics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$83.70 million, a 63.1% decrease year over year.
What was BNGO's earnings growth in the past year?
As of Bionano Genomics's earnings date in Invalid Date, Bionano Genomics's earnings has grown year over year. BNGO earnings in the past year totalled -$83.70 million.
What are Bionano Genomics's earnings expectations?
The current EPS estimate for Bionano Genomics's earnings report in Invalid Date is -$3.02.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.